Publicacións en colaboración con investigadores/as de Complexo Hospitalario Universitario de Santiago (47)

2024

  1. Ramipril After Transcatheter Aortic Valve Implantation in Patients Without Reduced Ejection Fraction: The RASTAVI Randomized Clinical Trial

    Journal of the American Heart Association, Vol. 13, Núm. 19, pp. e035460

  2. Validation of a new model of non-invasive functional assessment of coronary lesions by computer tomography fractional flow reserve

    REC: CardioClinics, Vol. 59, Núm. 1, pp. 35-45

2022

  1. Chronic use of renin–angiotensin–aldosterone inhibitors in hypertensive COVID-19 patients: Results from a Spanish registry and meta-analysis

    Medicina Clinica, Vol. 158, Núm. 7, pp. 315-323

  2. Differences Between Takotsubo and the Working Diagnosis of Myocardial Infarction With Nonobstructive Coronary Arteries

    Frontiers in Cardiovascular Medicine, Vol. 9

  3. Prognostic impact of renal function trajectories in patients with STEMI and kidney dysfunction undergoing primary percutaneous coronary intervention: An analysis of ten years all-comers registry

    Hellenic Journal of Cardiology, Vol. 66, pp. 1-10

  4. Rationale and design of the Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) randomized trial

    European Journal of Heart Failure, Vol. 24, Núm. 3, pp. 581-588

  5. Transcatheter versus surgical aortic valve replacement in patients with morbid obesity: a multicentre propensity score-matched analysis

    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, Vol. 18, Núm. 5, pp. e417-e427

2021

  1. Association between myocardial injury and prognosis of COVID-19 hospitalized patients, with or without heart disease. CARDIOVID registry

    Revista Espanola de Cardiologia, Vol. 74, Núm. 1, pp. 105-108

  2. Edoxaban versus vitamin K antagonist for atrial fibrillation after TAVR

    New England Journal of Medicine, Vol. 385, Núm. 23, pp. 2150-2160

  3. Impact of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on COVID-19 in a western population. CARDIOVID registry

    Revista Espanola de Cardiologia, Vol. 74, Núm. 2, pp. 175-182

  4. Impact of significant paravalvular leaks after transcatheter aortic valve implantation on anaemia and mortality

    Heart, Vol. 107, Núm. 6, pp. 497-502

  5. Impact of statins in patients with COVID-19

    Revista Espanola de Cardiologia, Vol. 74, Núm. 7, pp. 637-640

  6. Impact of the presence of heart disease, cardiovascular medications and cardiac events on outcome in COVID-19

    Cardiology journal, Vol. 28, Núm. 3, pp. 360-368

  7. Prognostic Impact of Change in Nutritional Risk on Mortality and Heart Failure After Transcatheter Aortic Valve Replacement

    Circulation. Cardiovascular interventions, Vol. 14, Núm. 2, pp. e009342

  8. Prognostic impact of left ventricular ejection fraction recovery in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: Analysis of an 11-year all-comers registry

    European Heart Journal: Acute Cardiovascular Care, Vol. 10, Núm. 8, pp. 898-908

  9. The COVID-19 lab score: an accurate dynamic tool to predict in-hospital outcomes in COVID-19 patients

    Scientific Reports, Vol. 11, Núm. 1

2020

  1. Intracoronary lithotripsy in a high-risk real-world population. First experience in severely calcified, complex coronary lesions

    REC: Interventional Cardiology, Vol. 2, Núm. 2, pp. 76-81

  2. Left ventricle myocardial deformation pattern in severe aortic valve stenosis without cardiac amyloidosis. The AMY-TAVI trial

    Revista Espanola de Cardiologia, Vol. 73, Núm. 11, pp. 961-964

  3. Ramipril in High-Risk Patients With COVID-19

    Journal of the American College of Cardiology, Vol. 76, Núm. 3, pp. 268-276

2019

  1. Impact of Coronary Revascularization in Patients Who Underwent Transcatheter Aortic Valve Implantation

    American Journal of Cardiology, Vol. 123, Núm. 6, pp. 948-955